TESSCO TECHNOLOGIES

 

TESSCO TECHNOLOGIES 2003

 

Annual Report

TABLE OF CONTENTS:  




Page 15 of 19      < Previous     Next >  


Item 8. Consolidated Financial Statements and Supplementary Data.

Consolidated Statements of Cash Flow


FISCAL YEARS ENDED

 

MARCH 30, 2003

 

MARCH 31, 2002

 

APRIL 1, 2001

Cash Flows from Operating Activities:

 

 

 

 

 

 
   Net Income

 

$ 3,048,600    

 

$ 3,905,900    

 

$ 5,274,000    
   Adjustments to reconcile net income to net cash provided by operating activities:

 

   

 

   

 

   
       Depreciation and amortization

 

3,984,900    

 

4,519,500    

 

3,652,800    
       Provision for bad debts

 

616,100    

 

823,300    

 

972,200    
       Deferred income taxes and other

 

552,100    

 

(166,800)   

 

1,150,400    
   (Increase) decrease in trade accounts receivable

 

(4,720,700)   

 

(3,376,900)   

 

1,647,400    
   Decrease (increase) in product inventory

 

11,840,800    

 

(5,914,100)   

 

(842,600)   
   Increase (decrease) in prepaid expenses and other current assets

 

(3,600,600)   

 

944,200    

 

(846,500)   
   Decrease (increase) in trade accounts payable

 

(1,134,400)   

 

11,392,900    

 

(8,609,200)   
   Increase in accrued expenses and other current liabilities

 

2,584,300    

 

1,584,300    

 

478,600    

          Net cash provided by operating activities

 

13,171,100    

 

13,712,300    

 

2,877,100    

Cash Flows from Investing Activities:

 

   

 

   

 

   
   Acquisition of property and equipment

 

(7,990,400)   

 

(8,412,000)   

 

(7,843,500)   

          Net cash used in investing activities

 

(7,990,400)   

 

(8,412,000)   

 

(7,843,500)   

Cash Flows from Financing Activities:

 

   

 

   

 

   
   Net (repayments) borrowings under revolving credit facility

 

(5,408,000)   

 

(4,603,000)   

 

4,149,000    
   Payments on long-term debt

 

(407,600)   

 

(354,500)   

 

(333,000)   
   Proceeds from issuance of stock

 

129,800    

 

162,300    

 

332,300    

          Net cash (used in) provided by financing activities

 

(5,685,800)   

 

(4,795,200)   

 

4,148,300    

          Net decrease (increase) in cash and cash equivalents

 

(505,100)   

 

505,100    

 

(818,100)   
Cash and Cash Equivalents, beginning of period

 

505,100    

 

---    

 

818,100    

Cash and Cash Equivalents, end of period

 

$               ---    

 

$     505,100    

 

$               ---    


The accompanying Notes to the Consolidated Financial Statements are an integral part of these consolidated statements.




Page 15 of 19      < Previous     Next >